CLINICAL_TRIALS
research
· 2016-02-23
Clinical Trial Update: Bio-enhanced Curcumin as an Add-On Treatment in Mild to Moderate Ulcerative Colitis [Phase 3]
Summary
A Phase 3 clinical trial is evaluating bio-enhanced curcumin as an add-on treatment for mild to moderate ulcerative colitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Asian Institute of Gastroenterology, India | Conditions: Ulcerative Colitis | Phase 3 | Status: UNKNOWN